Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Ellis

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancerC H Crane, N A Janjan, J L Abbruzzese, et al.
Oncogene|May 6, 2020
Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverM J Gray, N A Dallas, G Van Buren, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2000
Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancerN A Janjan, C N Crane, B W Feig, et al.
Oncogene|September 23, 2008
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverM J Gray, N A Dallas, G Van Buren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2K Chang, J A Willis, J Reumers, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancerC H Crane, N A Janjan, J L Abbruzzese, et al.
Oncogene|May 6, 2020
Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverM J Gray, N A Dallas, G Van Buren, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2000
Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancerN A Janjan, C N Crane, B W Feig, et al.
Oncogene|September 23, 2008
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liverM J Gray, N A Dallas, G Van Buren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2K Chang, J A Willis, J Reumers, et al.
Pageof 14